1-[[4-(aminomethyl)cyclohexyl]methyl]-3-(4-morpholin-4-ylphenyl)-N-phenylpyrazolo[3,4-d]pyrimidin-6-amine
C29H35N7O — CID 144944093
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[4-(aminomethyl)cyclohexyl]methyl]-3-(4-morpholin-4-ylphenyl)-N-phenylpyrazolo[3,4-d]pyrimidin-6-amine
1-[[4-(aminomethyl)cyclohexyl]methyl]-3-(4-morpholin-4-ylphenyl)-N-phenylpyrazolo[3,4-d]pyrimidin-6-amine (PubChem CID 144944093) has the molecular formula C29H35N7O and a molecular weight of 497.65 g/mol. Its IUPAC name is 1-[[4-(aminomethyl)cyclohexyl]methyl]-3-(4-morpholin-4-ylphenyl)-N-phenylpyrazolo[3,4-d]pyrimidin-6-amine.
Molecular Properties
| Compound Name | 1-[[4-(aminomethyl)cyclohexyl]methyl]-3-(4-morpholin-4-ylphenyl)-N-phenylpyrazolo[3,4-d]pyrimidin-6-amine |
|---|---|
| PubChem CID | 144944093 |
| Molecular Formula | C29H35N7O |
| Molecular Weight | 497.65 g/mol |
| Exact Mass | 497.29 |
| IUPAC Name | 1-[[4-(aminomethyl)cyclohexyl]methyl]-3-(4-morpholin-4-ylphenyl)-N-phenylpyrazolo[3,4-d]pyrimidin-6-amine |
| SMILES | NCC1CCC(Cn2nc(-c3ccc(N4CCOCC4)cc3)c3cnc(Nc4ccccc4)nc32)CC1 |
| InChI | InChI=1S/C29H35N7O/c30-18-21-6-8-22(9-7-21)20-36-28-26(19-31-29(33-28)32-24-4-2-1-3-5-24)27(34-36)23-10-12-25(13-11-23)35-14-16-37-17-15-35/h1-5,10-13,19,21-22H,6-9,14-18,20,30H2,(H,31,32,33) |
| InChIKey | AEGIXHVJGBJCCC-UHFFFAOYSA-N |
| XLogP | 4.84 |
| TPSA | 94.12 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 497.65 |
| LogP ≤ 5 | 4.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144944093 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.